REN Wei

This profile gathers the share dealings of REN Wei in Ascentage Pharma Group International. In total, 3 filings cover trades dated from 20 September 2021 to 26 November 2025.

The open-market record is one-sided, with 3 purchases and not one sale. The totals exclude 3 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 2 purchases and no sales on the market.

The record was last updated on 30 December 2025 with an open-market purchase in Ascentage Pharma Group International. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 34 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.